The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy:...

Por Engels, C. C., Charehbili, A., van de Velde, C. J. H., Bastiaannet, E., Sajet, A., Putter, H., van Vliet, E. A., van Vlierberghe, R. L. P., Smit, V. T. H. B. M., Bartlett, J. M. S., Seynaeve, C., Liefers, G. J., Kuppen, P. J. K.
Publicado no Breast Cancer Res Treat (2015)